Agency Forms Undergoing Paperwork Reduction Act Review, 8645-8646 [2021-02550]
Download as PDF
<![CDATA[
Federal Register / Vol. 86, No. 24 / Monday, February 8, 2021 / Notices
HISTORY:
86 FR 8645, February 8, 2021.
Terrell Dorn,
Managing Director, Infrastructure Operations/
Chief Agency Privacy Officer Government
Accountability Office.
[FR Doc. 2021–02554 Filed 2–4–21; 4:15 pm]
BILLING CODE 1610–02–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30 Day–21–1054]
jbell on DSKJLSW7X2PROD with NOTICES
Agency Forms Undergoing Paperwork
Reduction Act Review
In accordance with the Paperwork
Reduction Act of 1995, the Centers for
Disease Control and Prevention (CDC)
has submitted the information
collection request titled, ‘‘Drug
Overdose Response Investigation (DORI)
Data Collections’’ to the Office of
Management and Budget (OMB) for
review and approval. CDC previously
published a ‘‘Proposed Data Collection
Submitted for Public Comment and
Recommendations’’ notice on August
13,2020 to obtain comments from the
public and affected agencies. CDC did
not receive comments related to the
previous notice. This notice serves to
allow an additional 30 days for public
and affected agency comments.
CDC will accept all comments for this
proposed information collection project.
The Office of Management and Budget
is particularly interested in comments
that:
(a) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
(b) Evaluate the accuracy of the
agencies estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected;
(d) Minimize the burden of the
collection of information on those who
are to respond, including, through the
VerDate Sep<11>2014
21:24 Feb 05, 2021
Jkt 253001
use of appropriate automated,
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and
(e) Assess information collection
costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570.
Comments and recommendations for the
proposed information collection should
be sent within 30 days of publication of
this notice to www.reginfo.gov/public/
do/PRAMain Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function. Direct written
comments and/or suggestions regarding
the items contained in this notice to the
Attention: CDC Desk Officer, Office of
Management and Budget, 725 17th
Street NW, Washington, DC 20503 or by
fax to (202) 395–5806. Provide written
comments within 30 days of notice
publication.
Proposed Project
Drug Overdose Response Investigation
(DORI) Data Collections (OMB Control
No. 0920–1054, Exp. 03/31/2021)—
Extension—National Center for Injury
Prevention and Control (NCIPC),
Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
In 2015, CDC received OMB approval
(OMB Control No. 0920–1054) for this
Generic clearance for a three-year period
to collect information to response to
urgent requests from state and local
health authorities to provide
epidemiological information that allows
for the selection of interventions to curb
local epidemics of drug overdose. CDC
seeks OMB approval for an Extension of
this Generic clearance for a three-year
period.
Drug Overdose Response
Investigations (DORI) are to be
conducted in response to urgent
requests from state and local health
authorities to provide epidemiological
information that allows for the selection
of interventions to curb local epidemics
of drug overdose. Of particular interest
is response to increasing trends in, or
PO 00000
Frm 00068
Fmt 4703
Sfmt 4703
8645
changing characteristics of, overdose
from prescription drugs (with a special
interest in opioid analgesics such as
oxycodone or methadone;
benzodiazepines such as alprazolam)
and/or illicit drugs (e.g., heroin). CDC’s
National Center for Injury Prevention
and Control (NCIPC) is frequently called
upon to conduct DORIs at the request of
state or local health authorities seeking
support to respond to urgent public
health problems resulting from drug
use, misuse, addiction, and overdose.
Such requests are typically, but not
always, made through the Epi-Aid
mechanism; in most investigations,
CDC’s epidemiological response entails
rapid and flexible collection of data that
evolves during the investigation period.
Generic clearance is requested to
ensure that timely information is
collected during a DORI, which allows
NCIPC to maintain critical mission
function by working with state and local
health authorities to protect the public’s
health. During an unanticipated rise in
nonfatal or fatal drug overdose where
the substances responsible for the health
event need to be identified, drivers and
risk factors are undetermined, and/or
subgroups at risk need to be identified,
immediate action by CDC is necessary to
minimize or prevent public harm. CDC
must have the ability to rapidly deploy
data collection tools to understand the
scope of the problem and determine
appropriate action. Procedures for each
investigation, including specific data
collection plans, depend on the time
and resources available, number of
persons involved, and other
circumstances unique to the urgent
conditions at hand. Data are collected
by epidemiologists, psychologists,
medical professionals, subject matter
experts, and biostatisticians.
Data collected during a DORI are used
to understand sudden increases in drug
use and misuse associated with fatal
and nonfatal overdoses, understand the
drivers and risk factors associated with
those trends, and identify the groups
most affected. This allows CDC to
effectively advise states on actions that
could be taken to control the local
epidemic. During a DORI, data are
collected once, with the rare need for
follow-up. The estimated annual burden
hours are 2000, there are no costs to
respondents other than their time.
E:\FR\FM\08FEN1.SGM
08FEN1
8646
Federal Register / Vol. 86, No. 24 / Monday, February 8, 2021 / Notices
ESTIMATED ANNUALIZED BURDEN HOURS
Type of respondent
Form name
Number of
respondents
Number of
responses per
respondent
Average
burden per
response
(in hours)
Drug Overdose Response Investigation Participants
DORI Data Collection Instruments ......
4,000
1
30/60
Jeffrey M. Zirger,
Lead, Information Collection Review Office,
Office of Scientific Integrity, Office of Science,
Centers for Disease Control and Prevention.
[FR Doc. 2021–02550 Filed 2–5–21; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[30Day–21–20QN]
jbell on DSKJLSW7X2PROD with NOTICES
Agency Forms Undergoing Paperwork
Reduction Act Review
In accordance with the Paperwork
Reduction Act of 1995, the Centers for
Disease Control and Prevention (CDC)
has submitted the information
collection request titled ‘‘Availability,
Use, and Public Health Impact of
Emergency Supply Kits among DisasterAffected Populations’’ to the Office of
Management and Budget (OMB) for
review and approval. CDC previously
published a ‘‘Proposed Data Collection
Submitted for Public Comment and
Recommendations’’ notice on August
28, 2020 to obtain comments from the
public and affected agencies. CDC
received one comment related to the
previous notice. This notice serves to
allow an additional 30 days for public
and affected agency comments.
CDC will accept all comments for this
proposed information collection project.
The Office of Management and Budget
is particularly interested in comments
that:
(a) Evaluate whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility;
(b) Evaluate the accuracy of the
agencies estimate of the burden of the
proposed collection of information,
including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and
clarity of the information to be
collected;
(d) Minimize the burden of the
collection of information on those who
are to respond, including, through the
use of appropriate automated,
VerDate Sep<11>2014
20:48 Feb 05, 2021
Jkt 253001
electronic, mechanical, or other
technological collection techniques or
other forms of information technology,
e.g., permitting electronic submission of
responses; and
(e) Assess information collection
costs.
To request additional information on
the proposed project or to obtain a copy
of the information collection plan and
instruments, call (404) 639–7570.
Comments and recommendations for the
proposed information collection should
be sent within 30 days of publication of
this notice to www.reginfo.gov/public/
do/PRAMain Find this particular
information collection by selecting
‘‘Currently under 30-day Review—Open
for Public Comments’’ or by using the
search function. Direct written
comments and/or suggestions regarding
the items contained in this notice to the
Attention: CDC Desk Officer, Office of
Management and Budget, 725 17th
Street NW, Washington, DC 20503 or by
fax to (202) 395–5806. Provide written
comments within 30 days of notice
publication.
Proposed Project
Availability, Use, and Public Health
Impact of Emergency Supply Kits
among Disaster-Affected Populations—
New—National Center for
Environmental Health (NCEH), Centers
for Disease Control and Prevention
(CDC).
Background and Brief Description
The National Center for
Environmental Health (NCEH) is
submitting a New Information
Collection Request (ICR), for two-year
approval. NCEH will conduct this crosssectional study among two disasteraffected populations, at one site per
year. NCEH will select geographic sites
(e.g., city, town, region) for inclusion in
the study after a disaster (e.g., hurricane,
wildfire, flood, tornado) has occurred in
the area. Parameters for site selection
include a major or state-level disaster
declaration for a natural disaster that
affects a mid- to high-density area (e.g.,
population of 100,000 people) within
the United States.
An all-of-society approach to disaster
risk reduction emphasizes inclusion and
engagement in preparedness activities.
PO 00000
Frm 00069
Fmt 4703
Sfmt 4703
A common recommendation is to
promote household preparedness
through the preparation of an
emergency supply kit that can be used
to shelter-in-place or during evacuation.
Lack of household preparedness is a
public health concern, especially in
medically frail populations, because it
consumes first responders’ time, taking
them away from relief and recovery
efforts, and can easily deplete
community health resources. The
Federal Emergency Management Agency
(FEMA) states that individuals or
households are prepared for a disaster if
they have thought about and planned
for the types of disaster for which they
are at most risk, have developed a
family communication and evacuation
plan in the event of a disaster, and have
assembled a complete disaster
(emergency) supply kit. However, the
prevalence of emergency supply kits
across households in the United States
ranges considerably from a communitylevel low of 10% to a regional high of
68%. This lack and variation of
emergency supply kits across
households makes household disaster
preparedness a public health concern.
Self-sufficiency (defined as the ability
to shelter-in-place without needing to
leave your home or call for outside
assistance for ∼3 days following a
disaster) can help reduce the demands
placed on first responders during
critical times, which has downstream
public health impacts. Among persons
with an existing physical or mental
health condition at the time of the
disaster, having an adequate supply of
prescription and over-the-counter
medications and medical supplies
allows people to maintain treatment and
prevent worsening or exacerbation of
their existing condition or illness. It also
can reduce their need for emergency
medical services following a disaster.
The FEMA definition of an emergency
supply kit is one that can sustain each
member of a household with food,
water, and medication for up to three
days. However, there are several
knowledge gaps and challenges related
to emergency supply kit use and
effectiveness, including whether the
current recommendations are adequate
or need expansion. We identified the
following gaps:
E:\FR\FM\08FEN1.SGM
08FEN1
]]>Agencies
[Federal Register Volume 86, Number 24 (Monday, February 8, 2021)]
[Notices]
[Pages 8645-8646]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-02550]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[30 Day-21-1054]
Agency Forms Undergoing Paperwork Reduction Act Review
In accordance with the Paperwork Reduction Act of 1995, the Centers
for Disease Control and Prevention (CDC) has submitted the information
collection request titled, ``Drug Overdose Response Investigation
(DORI) Data Collections'' to the Office of Management and Budget (OMB)
for review and approval. CDC previously published a ``Proposed Data
Collection Submitted for Public Comment and Recommendations'' notice on
August 13,2020 to obtain comments from the public and affected
agencies. CDC did not receive comments related to the previous notice.
This notice serves to allow an additional 30 days for public and
affected agency comments.
CDC will accept all comments for this proposed information
collection project. The Office of Management and Budget is particularly
interested in comments that:
(a) Evaluate whether the proposed collection of information is
necessary for the proper performance of the functions of the agency,
including whether the information will have practical utility;
(b) Evaluate the accuracy of the agencies estimate of the burden of
the proposed collection of information, including the validity of the
methodology and assumptions used;
(c) Enhance the quality, utility, and clarity of the information to
be collected;
(d) Minimize the burden of the collection of information on those
who are to respond, including, through the use of appropriate
automated, electronic, mechanical, or other technological collection
techniques or other forms of information technology, e.g., permitting
electronic submission of responses; and
(e) Assess information collection costs.
To request additional information on the proposed project or to
obtain a copy of the information collection plan and instruments, call
(404) 639-7570. Comments and recommendations for the proposed
information collection should be sent within 30 days of publication of
this notice to www.reginfo.gov/public/do/PRAMain Find this particular
information collection by selecting ``Currently under 30-day Review--
Open for Public Comments'' or by using the search function. Direct
written comments and/or suggestions regarding the items contained in
this notice to the Attention: CDC Desk Officer, Office of Management
and Budget, 725 17th Street NW, Washington, DC 20503 or by fax to (202)
395-5806. Provide written comments within 30 days of notice
publication.
Proposed Project
Drug Overdose Response Investigation (DORI) Data Collections (OMB
Control No. 0920-1054, Exp. 03/31/2021)--Extension--National Center for
Injury Prevention and Control (NCIPC), Centers for Disease Control and
Prevention (CDC).
Background and Brief Description
In 2015, CDC received OMB approval (OMB Control No. 0920-1054) for
this Generic clearance for a three-year period to collect information
to response to urgent requests from state and local health authorities
to provide epidemiological information that allows for the selection of
interventions to curb local epidemics of drug overdose. CDC seeks OMB
approval for an Extension of this Generic clearance for a three-year
period.
Drug Overdose Response Investigations (DORI) are to be conducted in
response to urgent requests from state and local health authorities to
provide epidemiological information that allows for the selection of
interventions to curb local epidemics of drug overdose. Of particular
interest is response to increasing trends in, or changing
characteristics of, overdose from prescription drugs (with a special
interest in opioid analgesics such as oxycodone or methadone;
benzodiazepines such as alprazolam) and/or illicit drugs (e.g.,
heroin). CDC's National Center for Injury Prevention and Control
(NCIPC) is frequently called upon to conduct DORIs at the request of
state or local health authorities seeking support to respond to urgent
public health problems resulting from drug use, misuse, addiction, and
overdose. Such requests are typically, but not always, made through the
Epi-Aid mechanism; in most investigations, CDC's epidemiological
response entails rapid and flexible collection of data that evolves
during the investigation period.
Generic clearance is requested to ensure that timely information is
collected during a DORI, which allows NCIPC to maintain critical
mission function by working with state and local health authorities to
protect the public's health. During an unanticipated rise in nonfatal
or fatal drug overdose where the substances responsible for the health
event need to be identified, drivers and risk factors are undetermined,
and/or subgroups at risk need to be identified, immediate action by CDC
is necessary to minimize or prevent public harm. CDC must have the
ability to rapidly deploy data collection tools to understand the scope
of the problem and determine appropriate action. Procedures for each
investigation, including specific data collection plans, depend on the
time and resources available, number of persons involved, and other
circumstances unique to the urgent conditions at hand. Data are
collected by epidemiologists, psychologists, medical professionals,
subject matter experts, and biostatisticians.
Data collected during a DORI are used to understand sudden
increases in drug use and misuse associated with fatal and nonfatal
overdoses, understand the drivers and risk factors associated with
those trends, and identify the groups most affected. This allows CDC to
effectively advise states on actions that could be taken to control the
local epidemic. During a DORI, data are collected once, with the rare
need for follow-up. The estimated annual burden hours are 2000, there
are no costs to respondents other than their time.
[[Page 8646]]
Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
Number of Average burden
Type of respondent Form name Number of responses per per response
respondents respondent (in hours)
----------------------------------------------------------------------------------------------------------------
Drug Overdose Response Investigation DORI Data Collection 4,000 1 30/60
Participants. Instruments.
----------------------------------------------------------------------------------------------------------------
Jeffrey M. Zirger,
Lead, Information Collection Review Office, Office of Scientific
Integrity, Office of Science, Centers for Disease Control and
Prevention.
[FR Doc. 2021-02550 Filed 2-5-21; 8:45 am]
BILLING CODE 4163-18-P
